The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 30, 2014

Filed:

Mar. 16, 2012
Applicants:

Stephen T. Wrobleski, Flemington, NJ (US);

Gregory D. Brown, Landsdale, PA (US);

Lidia M. Doweyko, Vero Beach, FL (US);

Jingwu Duan, Yardley, PA (US);

Junqing Guo, Princeton, NJ (US);

John Hynes, Washington Crossing, PA (US);

Bin Jiang, Norristown, PA (US);

James Kempson, Princeton, NJ (US);

Shuqun Lin, Newtown, PA (US);

Zhonghui LU, King of Prussia, PA (US);

Steven H. Spergel, Warrington, PA (US);

John S. Tokarski, Princeton, NJ (US);

Hong Wu, New Hope, PA (US);

Bingwei Vera Yang, Belle Mead, NJ (US);

Inventors:

Stephen T. Wrobleski, Flemington, NJ (US);

Gregory D. Brown, Landsdale, PA (US);

Lidia M. Doweyko, Vero Beach, FL (US);

Jingwu Duan, Yardley, PA (US);

Junqing Guo, Princeton, NJ (US);

John Hynes, Washington Crossing, PA (US);

Bin Jiang, Norristown, PA (US);

James Kempson, Princeton, NJ (US);

Shuqun Lin, Newtown, PA (US);

Zhonghui Lu, King of Prussia, PA (US);

Steven H. Spergel, Warrington, PA (US);

John S. Tokarski, Princeton, NJ (US);

Hong Wu, New Hope, PA (US);

Bingwei Vera Yang, Belle Mead, NJ (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 471/04 (2006.01); A01N 43/58 (2006.01); A61K 31/50 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed are compounds of Formula (I), and pharmaceutically acceptable salts thereof. The compounds of formula (I) inhibit tyrosine kinase activity of JAK3, thereby making them useful for the treatment of inflammatory and autoimmune diseases.


Find Patent Forward Citations

Loading…